Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca’s potential drug for neuromyelitis optica spectrum disorder receives EU orphan designati

europeanpharmaceuticalreviewMarch 31, 2017

Tag: neuromyelitis optica spectrum disorder

PharmaSources Customer Service